|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2003-7-31
|
|
pubmed:abstractText |
The aim of the first Nordic mantle cell lymphoma (MCL) protocol was to study the clinical significance of an augmented CHOP induction chemotherapy followed by high-dose chemotherapy and autologous stem cell transplantation (ASCT) and to examine the prognostic significance of stem cell contamination rates in newly diagnosed patients with MCL.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0902-4441
|
|
pubmed:author |
pubmed-author:AkermanMånsM,
pubmed-author:AndersenNiels SNS,
pubmed-author:ElonenErkkiE,
pubmed-author:ErikssonMikaelM,
pubmed-author:FranssilaKaarleK,
pubmed-author:GeislerChristian HCH,
pubmed-author:JohnsonAnnaA,
pubmed-author:KolstadArneA,
pubmed-author:KuittinenOutiO,
pubmed-author:LangholmRuthR,
pubmed-author:Nordic Lymphoma Group,
pubmed-author:PedersenLoneL,
pubmed-author:RalfkiaerElisabethE
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
71
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
73-80
|
|
pubmed:dateRevised |
2008-11-21
|
|
pubmed:meshHeading |
pubmed-meshheading:12890145-Adult,
pubmed-meshheading:12890145-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:12890145-Blood Component Removal,
pubmed-meshheading:12890145-Cyclophosphamide,
pubmed-meshheading:12890145-Female,
pubmed-meshheading:12890145-Humans,
pubmed-meshheading:12890145-Immunomagnetic Separation,
pubmed-meshheading:12890145-Lymphoma, Mantle-Cell,
pubmed-meshheading:12890145-Male,
pubmed-meshheading:12890145-Middle Aged,
pubmed-meshheading:12890145-Neoplastic Cells, Circulating,
pubmed-meshheading:12890145-Peripheral Blood Stem Cell Transplantation,
pubmed-meshheading:12890145-Prednisone,
pubmed-meshheading:12890145-Remission Induction,
pubmed-meshheading:12890145-Survival Analysis,
pubmed-meshheading:12890145-Transplantation, Autologous,
pubmed-meshheading:12890145-Treatment Outcome,
pubmed-meshheading:12890145-Vincristine
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Primary treatment with autologous stem cell transplantation in mantle cell lymphoma: outcome related to remission pretransplant.
|
|
pubmed:affiliation |
Department of Hematology, Rigshospitalet, Copenhagen, Denmark. andersen1000@hotmail.com
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase II
|
